Cargando…

It might be a wonderful opportunity when patients with a psychotic disorder use cannabis

Detalles Bibliográficos
Autor principal:	de Haan, Lieuwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961333/ https://www.ncbi.nlm.nih.gov/pubmed/35074041 http://dx.doi.org/10.1017/S0033291721003561

Ejemplares similares

Evidence for a Shared Etiological Mechanism of Psychotic Symptoms and Obsessive-Compulsive Symptoms in Patients with Psychotic Disorders and Their Siblings
por: Swets, Marije, et al.
Publicado: (2015)

Meta-analysis of cognitive functioning in patients with psychotic disorders and obsessive–compulsive symptoms
por: Dijkstra, Lotte, et al.
Publicado: (2020)

Wonders of discovery
por: Damle, S. G.
Publicado: (2011)

Wonders of Surgery
Publicado: (1890)

Wild and Wonderful…
por: Zimmerman, Karen G., et al.
Publicado: (2018)

Avatar Intervention for cannabis use disorder in patients with psychotic and mood disorders
por: Giguère, S., et al.
Publicado: (2023)

Misuse of Wonder Drugs
Publicado: (1952)

Obsessive–compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings
por: Schirmbeck, Frederike, et al.
Publicado: (2016)

A Wonderful Piece of Mechanism
Publicado: (1885)

The Marlin Wonder
Publicado: (1897)

Gout, tophi and the wonders of NETs
por: Pisetsky, David S
Publicado: (2014)

Autistic traits in psychotic disorders: prevalence, familial risk, and impact on social functioning
por: Ziermans, Tim B., et al.
Publicado: (2021)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
por: Sami, Musa Basseer, et al.
Publicado: (2018)

Attachment Style and Self-Experience: The Association Between Attachment Style and Self-Reported Altered Self-Experience in Patients With Psychotic Disorders, Unaffected Siblings, and Healthy Controls
por: de With, Justine, et al.
Publicado: (2023)

Obsessive–compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels
por: Schirmbeck, Frederike, et al.
Publicado: (2018)

Dexmedetomidine in anaesthesia practice: A wonder drug?
por: Sudheesh, K, et al.
Publicado: (2011)

A journal called “I wonder why not”
por: English, Denis
Publicado: (2011)

Lawson Tait’s Wonderful Success in Ovariatory
Publicado: (1886)

Epigenetics and cancer disparities: when nature might be nurture
por: Jordan, I. King, et al.
Publicado: (2022)

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
por: Di Forti, Marta, et al.
Publicado: (2019)

“ChatGPT” – Is it a New Wonder Drug in the Trial?
por: Muthu, Sathish, et al.
Publicado: (2023)

Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful
por: Solanki, Sohan Lal, et al.
Publicado: (2015)

COVID-19 and hydroxychloroquine: Is the wonder drug failing?
por: Paliani, Ugo, et al.
Publicado: (2020)

Endless microbes most beautiful and most wonderful
por: Barsh, Gregory S., et al.
Publicado: (2023)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
por: Elias De Sousa, A., et al.
Publicado: (2022)

T87. CHANGING RATES OF PAST-YEAR CANNABIS USE BY PEOPLE WITH A PSYCHOTIC DISORDER
por: Waterreus, Anna, et al.
Publicado: (2020)

The Negro, Major Shufeldt’s Wonderful Book
Publicado: (1908)

Wonder and the Patient
por: Evans, H. M.
Publicado: (2014)

Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022)

Wonderful
Publicado: (1861)

Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
por: Datta, Shivika, et al.
Publicado: (2021)

Collection Overview: Ten Years of Wonderful Open Access Science
por: Roberts, Roland G., et al.
Publicado: (2013)

T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Bogers, Jan, et al.
Publicado: (2020)

Multiple inpatient admissions for cannabis-induced psychotic disorder - sociodemographic, clinical and treatment evaluation
por: Machado, A.S., et al.
Publicado: (2022)

Active or Healthy Ageing: “A Wonderful Journey between Body, Cognition and Emotion”
por: Dias, Gonçalo
Publicado: (2022)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

No wonder you wonder!: great inventions and scientific mysteries
por: Phipps, Claude
Publicado: (2016)

Cognitive impairment in first psychotic episodes: The role of cannabis
por: Boi, S., et al.
Publicado: (2021)

Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder
por: van der Leeuw, Christine, et al.
Publicado: (2013)

Knowledge and wonder
por: Maurice Jacob
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_maes48l2jd8ihorchl4pcnggig